| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2023 ( Subtotal = $3,163,508 ) |
| | 2023 | 2023 | LIBERO PHARMA LIMITED | INTERNATIONAL HOUSE | EDINBURGH | | | | GBR | UG3DA057853 | Naltrexone Transdermal Patch - An Accessible, Patient-Focused Option to Treat OUD Relapse | 002 | 2 | NIH | 8/16/2023 | $3,163,508 |
| | 2023 | 2022 | LIBERO PHARMA LIMITED | 30 SEMPLE STREET | EDINBURGH | | | | GBR | UG3DA057853 | Naltrexone Transdermal Patch - An Accessible, Patient-Focused Option to Treat OUD Relapse | 000 | 1 | NIH | 10/13/2022 | $0 |
| | 2023 | 2022 | LIBERO PHARMA LIMITED | INTERNATIONAL HOUSE | EDINBURGH | | | | GBR | UG3DA057853 | Naltrexone Transdermal Patch - An Accessible, Patient-Focused Option to Treat OUD Relapse | 001 | 1 | NIH | 11/21/2022 | $0 |
|
| Issue Date FY: 2022 ( Subtotal = $3,187,507 ) |
| | 2022 | 2022 | LIBERO PHARMA LIMITED | 30 SEMPLE STREET | EDINBURGH | | | | GBR | UG3DA057853 | Naltrexone Transdermal Patch - An Accessible, Patient-Focused Option to Treat OUD Relapse | 000 | 1 | NIH | 9/21/2022 | $3,187,507 |
|
|
